Literature DB >> 22241009

Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients.

Carl-Johan Jakobsen1, Pia Katarina Ryhammer, Mariann Tang, Jan Jesper Andreasen, Poul Erik Mortensen.   

Abstract

OBJECTIVE: Numerous reports have emphasized the need for reduction in transfusions of allogeneic red blood cells (RBC) due to increased morbidity and mortality. Nevertheless, transfusion rates are still high in several cardiac surgery institutions. Reports on long-term survival after cardiac surgery and RBC transfusion are few.
METHODS: Data from the Western Denmark Heart Registry (WDHR) were used to identify all (25,117) adult cardiac surgery performed in four centres during 1999-2010. Patients with multiple entries (1049), re-do cardiac surgery (985), special/complex procedures (2329), dying within 30 days (668) and not eligible for follow-up (85) were excluded leaving a cohort of 20,001. Registration in the WDHR is mandatory. WDHR and the unique Danish Civil Registration System with continuous sequential updates of the Danish population ensure that all patients and outcomes are accounted for.
RESULTS: Kaplan-Meier survival plot for low-risk patients (EuroSCORE 0-4), undergoing simple cardiac surgery showed a significantly lower estimated survival after >4500 days (0.637 vs. 0.745) when receiving perioperative RBC transfusion (P<0.0001). The difference was less evident in patients with EuroSCORE 5-9 (0.373 vs. 0.4436, P<0.0001), while high-risk patients showed no difference. Adjusted risk ratio, after RBC transfusion, containing among others age, sex, EuroSCORE and diabetes, was 1.83 (95% CI (confidence interval) 1.67-2.01). The survival rate was independent of up till six units of RBC.
CONCLUSION: Long-term follow-up of low-risk patients undergoing simple cardiac surgery demonstrates a more than 10% higher mortality when receiving perioperative RBC transfusion. Even transfusion of 1-2 units seems to carry a risk of that magnitude.

Entities:  

Mesh:

Year:  2012        PMID: 22241009     DOI: 10.1093/ejcts/ezr242

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

1.  The relationship between total arterial revascularization and blood transfusion following coronary artery bypass grafting.

Authors:  Jasmina Djordjevic; Dumbor L Ngaage
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

Review 2.  The Effect of Blood Transfusion on Outcomes in Aortic Surgery.

Authors:  Camilo A Velasquez; Mrinal Singh; Syed Usman Bin Mahmood; Adam J Brownstein; Mohammad A Zafar; Ayman Saeyeldin; Bulat A Ziganshin; John A Elefteriades
Journal:  Int J Angiol       Date:  2017-07-27

3.  A model-based cost-effectiveness analysis of Patient Blood Management.

Authors:  Adina Kleinerüschkamp; Patrick Meybohm; Niels Straub; Kai Zacharowski; Suma Choorapoikayil
Journal:  Blood Transfus       Date:  2018-02-16       Impact factor: 3.443

4.  Early Chest Re-Exploration for Excessive Bleeding in Post Cardiac Surgery Patients: Does It Matter?

Authors:  Mujahid Ul Islam; Imtiaz Ahmad; Bahauddin Khan; Azam Jan; Niaz Ali; Waasay Hassan Khan; Omer Farooq; Hooria Khan; Faizan Ahmad Ali; Muhammad Shahid
Journal:  Cureus       Date:  2021-05-18

5.  Rate of repair in minimally invasive mitral valve surgery.

Authors:  Patrick Perier; Wolfgang Hohenberger; Fitsum Lakew; Gerhard Batz; Anno Diegeler
Journal:  Ann Cardiothorac Surg       Date:  2013-11

6.  Relative impact of red blood cell transfusion and anaemia on 5-year mortality in cardiac surgery.

Authors:  Long Tran; Guri Greiff; Alexander Wahba; Hilde Pleym; Vibeke Videm
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08

7.  Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures.

Authors:  Roberto Caporale; Giovanna Geraci; Michele Massimo Gulizia; Mauro Borzi; Furio Colivicchi; A Menozzi; Giuseppe Musumeci; Marino Scherillo; Antonietta Ledda; Giuseppe Tarantini; Piersilvio Gerometta; Giancarlo Casolo; Dario Formigli; Francesco Romeo; Roberto Di Bartolomeo
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

8.  Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery.

Authors:  Miguel Sousa-Uva; Robert Storey; Kurt Huber; Volkmar Falk; Adelino F Leite-Moreira; Julien Amour; Nawwar Al-Attar; Raimondo Ascione; David Taggart; Jean-Philippe Collet
Journal:  Eur Heart J       Date:  2014-04-18       Impact factor: 29.983

Review 9.  Transfusion strategy: impact of haemodynamics and the challenge of haemodilution.

Authors:  Carl-Johan Jakobsen
Journal:  J Blood Transfus       Date:  2014-08-06

10.  Implementation of an institutional protocol for rational use of blood products and its impact on postoperative of coronary artery bypass graft surgery.

Authors:  Pedro Gabriel Melo de Barros E Silva; Dimas Tadahiro Ikeoka; Viviane Aparecida Fernandes; Nilza Sandra Lasta; Debora Prudencio E Silva; Mariana Yumi Okada; Beatriz Akinaga Izidoro; José Carlos Teixeira Garcia; Antonio Claudio do Amaral Baruzzi; Valter Furlan
Journal:  Einstein (Sao Paulo)       Date:  2013 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.